News Focus
News Focus
Followers 43
Posts 4667
Boards Moderated 0
Alias Born 09/01/2017

Re: dstock07734 post# 724389

Sunday, 10/06/2024 8:32:44 PM

Sunday, October 06, 2024 8:32:44 PM

Post# of 819922
Looks to me they are trying to commercialize a very similar (in concept) immunotherapy vaccine platform, so similar that one wonders about whether they are infringing or intend on licensing the nwbo patents.

However I remember something about the DCs/vaccine themselves not being patentable but rather the production process and key features being what the patents sre on, as well as a broad combination of dcvax set of patents.

Are you suggesting a direct connection between the companies and/or their products, as in dcvax being used or the IP licensed?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News